Tomorrow is my psm practical exam of mbbs 2nd year from nepal. I dont know about RDA . External maam surely ask me RDA . Could you please provide me about RDA in easy language so that i will never forget it . And the external will impress
ICMR RDA recommended dietary allowance India 2020 PSM MBBS values table
RDA (Recommended Dietary Allowance) is the average daily dietary intake of a nutrient that is sufficient to meet the nutritional requirements of nearly all (97-98%) healthy individuals of a specific age, sex, and physiological state.
| Short Form | Full Name | What it means | % covered |
|---|---|---|---|
| EAR | Estimated Average Requirement | Meets needs of 50% of healthy people | 50% |
| RDA | Recommended Dietary Allowance | Meets needs of 97-98% of healthy people | 97-98% |
| AI | Adequate Intake | Used when EAR/RDA cannot be calculated | Not defined |
| UL | Tolerable Upper Intake Level | Maximum safe intake - above this, adverse effects start | - |

RDA = EAR + 2 SD (standard deviations)
| Group | Energy (kcal/day) |
|---|---|
| Adult Man (moderate work) | 2710 kcal |
| Adult Woman (moderate work) | 2130 kcal |
| Pregnant woman (2nd trimester extra) | +350 kcal |
| Lactating woman (0-6 months extra) | +600 kcal |
| Group | Protein (g/day) | Formula |
|---|---|---|
| Adult Man | 54 g | 0.83 g/kg/day |
| Adult Woman | 46 g | 0.83 g/kg/day |
| Pregnant (2nd trimester) | +9.5 g extra | |
| Pregnant (3rd trimester) | +22 g extra | |
| Lactating (0-6 months) | +17 g extra |
Note: ICMR 2020 changed protein RDA from 1.0 g/kg/day (old 2010 value) to 0.83 g/kg/day based on DIAAS (Digestible Indispensable Amino Acid Score) - this impresses examiners!
| Nutrient | Adult Man | Adult Woman | Pregnant | Lactating |
|---|---|---|---|---|
| Calcium | 1000 mg | 1000 mg | 1000 mg | 1200 mg |
| Iron | 19 mg | 29 mg | 35 mg | - |
| Zinc | 17 mg | 13 mg | 14.5 mg | 14 mg |
| Iodine | 150 µg | 150 µg | 200 µg | 200 µg |
| Nutrient | Adult Man | Adult Woman |
|---|---|---|
| Vitamin A | 1000 µg | 840 µg |
| Vitamin C | 80 mg | 65 mg |
| Vitamin D | 600 IU | 600 IU |
| Folate | 300 µg | 220 µg |
| Vitamin B12 | 2.2 µg | 2.2 µg |
| Factor | Effect |
|---|---|
| Age | Children, adolescents, elderly have different values |
| Sex | Men and women differ (e.g., iron - women need more due to menstruation) |
| Pregnancy | Increased requirements for almost all nutrients |
| Lactation | Extra energy, protein, calcium needed |
| Physical activity | More activity = more energy needed |
| Physiological state | Illness, malabsorption affect needs |
| Bioavailability | Nutrient form and food matrix affect absorption (e.g., iron from plant foods = lower bioavailability) |
RDA = Average daily intake sufficient for 97-98% healthy people
= EAR + 2 SD
= Part of DRI system: EAR → RDA → AI → UL
= Set by ICMR-NIN for India (latest: 2020)
Key values (adult, moderate work):
Energy: Man 2710, Woman 2130 kcal/day
Protein: Man 54g, Woman 46g (0.83 g/kg/day)
Calcium: 1000 mg/day
Iron: Man 19 mg, Woman 29 mg/day
Vitamin D: 600 IU/day
Create a quick reference PDF summary of RDA values I can print tonight
Create a quick reference PDF summary of RDA
RDA Quick Reference
PDF Document · PDF
This pdf is not openinhg in my macbook m2
RDA Quick Reference LO
PDF Document · PDF
RDA Quick Reference
HTML File · HTML
Tomorrow is my psm practical exam of mbbs 2nd year from nepal. I dont know about rubella and mumps . External maam surely ask me from this pptx . Could you please provide me about rubella and mumps in easy language so that i will never forget it . And the external will impress
Rubella is a mild, self-limiting viral illness caused by Rubella virus (RNA virus, Togavirus family) - also called "German Measles" or "3-day measles" (rash lasts only 3 days).
| Feature | Detail |
|---|---|
| Causative agent | Rubella virus (RNA virus, Togavirus) |
| Reservoir | Humans only (no animal reservoir) |
| Source | Infected persons (including subclinical cases) |
| Transmission | Droplet infection (respiratory route) |
| Communicability | 7 days before to 7 days after rash appears |
| Incubation period | 14-21 days (average 18 days) |
| Contagiousness | Less contagious than measles |
| Seasonality | Late winter to early spring |
| Age group | Children 5-15 years most affected |
| Feature | Measles | Rubella |
|---|---|---|
| Other name | Hard measles | German measles / 3-day measles |
| Virus | Paramyxovirus (Morbillivirus) | Togavirus |
| Rash duration | 4-7 days | 3 days |
| Rash type | Maculopapular, coalescent | Maculopapular, discrete |
| Koplik spots | Present (pathognomonic) | Absent |
| Lymphadenopathy | Cervical | Occipital + post-auricular |
| Fever | High | Low grade / absent |
| Incubation period | 10-12 days | 14-21 days (avg 18 days) |
| Severity | More severe | Milder |
| Danger in pregnancy | Less | Extremely dangerous (CRS) |
| Catarrhal stage | Present (3C's) | Absent |
"CCC" = Cataract + Cardiac defects + Cochlear deafness
| System | Defect |
|---|---|
| Eyes | Congenital cataract, glaucoma, retinopathy |
| Heart | Patent Ductus Arteriosus (PDA), VSD, pulmonary artery stenosis |
| Ears | Sensorineural deafness (most common single defect) |
| Brain | Microcephaly, intellectual disability |
| Other | Hepatosplenomegaly, thrombocytopenic purpura ("blueberry muffin baby") |
| Trimester | Risk of CRS |
|---|---|
| 1st (1-12 weeks) | Up to 90% - MOST DISASTROUS |
| 2nd (13-24 weeks) | 10-20% |
| After 16-20 weeks | Rare/no major defects |
| Test | What it shows |
|---|---|
| IgM antibodies at birth | Confirms CRS in newborn (IgM does NOT cross placenta → if present = baby made it) |
| IgG antibodies persist >6 months | Also confirms CRS (maternal IgG disappears by 6 months; if still present = baby's own) |
| Virus isolation | From throat, urine, CSF |
| PCR | Detect viral RNA |
| Question | Answer | Key reason |
|---|---|---|
| Vaccination priority during rubella outbreak | Women 15-49 years (non-pregnant) | Prevent CRS |
| Max fetal damage in | 6-12 weeks pregnancy (1st trimester) | Organogenesis |
| Rubella incubation period | 14-21 days, avg 18 days (NOT <10 days) | Important exception |
| Infection after 16 weeks | No major abnormalities | Safe window |
| CRS diagnosed by | IgM at birth OR IgG persisting >6 months | Both correct |
Mumps is an acute viral illness caused by Mumps virus (RNA virus, Paramyxovirus family - Rubulavirus genus) characterized by painful swelling of the parotid glands (parotitis).
| Feature | Detail |
|---|---|
| Causative agent | Mumps virus (RNA virus, Paramyxovirus) |
| Reservoir | Humans only |
| Transmission | Droplet infection + direct contact with infected saliva |
| Incubation period | 16-18 days (range 12-25 days) - MCQ answer = 18 days |
| Communicability | 2 days before to 9 days after parotitis starts |
| Peak age | School-age children (5-14 years) |
| Seasonality | Late winter to spring |
| Immunity | Lifelong after natural infection |
| Complication | Frequency (unvaccinated) | Key points |
|---|---|---|
| Aseptic meningitis | Up to 10% | Most common in children; self-limiting |
| Orchitis | 30% of post-pubertal males | Develops 1st week of parotitis; 30-50% testicular atrophy |
| Oophoritis | 7% of post-pubertal women | Ovarian inflammation |
| Pancreatitis | ~4% | Elevated amylase + lipase |
| Encephalitis | <1% | Mortality 1.5% |
| Hearing loss | Up to 4% | Usually unilateral, transient |
| Mastitis | 30% unvaccinated women | - |
| Method | Detail |
|---|---|
| Clinical | Painful bilateral parotid swelling + epidemiological history |
| Serology | IgM antibodies in acute phase (diagnostic) |
| Elevated serum amylase | Suggests parotitis or pancreatitis |
| Elevated lipase (with amylase) | Suggests pancreatitis specifically |
| PCR | Virus from saliva, urine, CSF |
| Question | Answer | Why |
|---|---|---|
| Most common complication of mumps in children | Aseptic meningitis | Orchitis is post-pubertal males only |
| Incubation period of mumps | 18 days | Range 12-25 days |
| Feature | Rubella | Mumps |
|---|---|---|
| Virus family | Togavirus | Paramyxovirus (Rubulavirus) |
| Virus type | RNA | RNA |
| Incubation | 18 days (14-21) | 18 days (12-25) |
| Key sign | Rash + occipital LN | Parotitis (swollen cheeks) |
| Koplik spots | No | No |
| Most dangerous in | Pregnancy (CRS) | Post-pubertal males (orchitis) |
| Most common complication | Subclinical (50%) | Aseptic meningitis (children) / Orchitis (adults) |
| Vaccine | MMR (live attenuated) | MMR (live attenuated) |
| Treatment | Symptomatic | Symptomatic |
Create a printable quick reference cheat sheet for Rubella & Mumps
Rubella Mumps Cheatsheet
PDF Document · PDF
cheatsheet
HTML File · HTML
| Section | What's inside |
|---|---|
| 🔴 Rubella basics | Virus, incubation, transmission, clinical features, diagnosis |
| 🔵 Mumps basics | Virus, parotitis features, management, diagnosis |
| ⭐ CRS section | Gregg's triad, risk by trimester, all defects, IgM vs IgG logic |
| ⚡ Mumps complications | Full table with %, orchitis facts, the children vs adult MCQ rule |
| 💉 MMR vaccine | Schedule, strains, contraindications, rubella outbreak strategy |
| ⚖️ Measles vs Rubella | Full comparison table - 13 features |
| 📝 MCQ bank | All 8 MCQs directly from your teacher's slides with answers |
| 🌟 Exam tips | 6 impressive lines to say to the external examiner |
Tomorrow is my psm practical exam of mbbs 2nd year from nepal. I dont know about chickenpox and smallpox . External maam surely ask me this topic . Could you please provide me about chicken pox and small pox from k park psm in easy language so that i will never forget it . And the external will impress
Chickenpox is an acute, highly infectious disease caused by Varicella-Zoster Virus (VZV), also called Human (alpha) Herpesvirus 3, characterized by a vesicular rash with fever and malaise.
| Feature | Detail |
|---|---|
| Agent | VZV — Human (alpha) Herpesvirus 3, DNA virus |
| Source | Cases of chickenpox; rarely herpes zoster patients |
| Virus in | Oropharyngeal secretions + lesions of skin and mucosa |
| Scabs | Scabs are NOT infective (virus dies before pustular stage) |
| Complication | Notes |
|---|---|
| Secondary bacterial infection | Most common; Group A Strep, Staph aureus |
| Cellulitis, erysipelas, osteomyelitis | Bacterial complications |
| Pneumonia | Especially in adults |
| Encephalitis / Cerebellar ataxia | Neurological |
| Reye's syndrome | If aspirin given — NEVER give aspirin! |
| Herpes Zoster | Latent virus reactivates later in life |
| Disseminated disease, DIC | In immunocompromised (rapidly fatal) |
| Pitted scars | Frequent sequelae |
Smallpox is an acute infectious disease caused by Variola virus, characterized by sudden fever, headache, backache, vomiting, and on the 3rd day a typical rash appearing in a centrifugal distribution passing through macule → papule → vesicle → pustule → scab with subsequent scarring.
| Feature | Detail |
|---|---|
| Agent | Variola virus — DNA virus, Poxvirus family (Orthopoxvirus) |
| Types | Variola major (CFR ~30%) and Variola minor (CFR ~1%) |
| Reservoir | Humans only — NO animal reservoir |
| Transmission | Droplet + direct contact; scabs are infective |
| Incubation | 12 days (range: 7–17 days) |
| CFR | Variola major: ~30% (highest in pregnant women, infants, elderly) |
| Event | Date |
|---|---|
| WHO intensified eradication campaign | 1967 |
| Strategy used | Surveillance & Containment (ring vaccination — NOT mass vaccination) |
| Last case in India | 24 May 1975 |
| India declared smallpox-free | 5 July 1975 |
| Last natural case worldwide | Somalia, 1977 |
| Global eradication confirmed | WHO, May 1980 |
| Virus still stored at | CDC Atlanta (USA) + VECTOR Institute (Russia) |
| WHO reserve stockpile | Vaccine for >200 million people |
| Feature | CHICKENPOX | SMALLPOX |
|---|---|---|
| Agent | VZV (Herpesvirus) | Variola (Poxvirus) |
| Incubation | 15 days (7–21) | 12 days (7–17) |
| Prodrome | Mild or absent | Severe |
| Rash distribution | CENTRIPETAL (trunk first) | CENTRIFUGAL (face first) |
| Palms & soles | Usually SPARED | Frequently involved |
| Axilla | Involved | Usually free |
| Rash surface | Flexor surfaces | Extensor + bony prominences |
| Vesicle type | Superficial, unilocular, dew-drop | Deep, multilocular, umbilicated |
| Inflammation around vesicle | PRESENT | ABSENT |
| Rash type | PLEOMORPHIC (all stages together) | MONOMORPHIC (one stage at a time) |
| Rash evolution | Very rapid (scabs in 4–7 days) | Slow, majestic (scabs in 10–14 days) |
| Fever pattern | Rises with each new crop | Secondary rise in pustular stage |
| Scabs | NOT infective | Infective |
| CFR | ~3 per 100,000 | ~30% (variola major) |
| Treatment | Acyclovir | No specific treatment |
Chickenpox Smallpox Cheatsheet
PDF Document · PDF
cheatsheet
HTML File · HTML
Create a quick-reference comparison card: Measles vs Rubella vs Chickenpox vs Smallpox
Measles Rubella Chickenpox Smallpox Comparison
PDF Document · PDF
card
HTML File · HTML
| Section | Content |
|---|---|
| Main comparison table | 30+ rows covering aetiology, prodrome, rash characteristics, LN, fever, complications, treatment, vaccine, current status — all 4 diseases side by side |
| Colour coding | 🔴 Red = Measles, 🟢 Teal = Rubella, 🟠 Orange = Chickenpox, 🟣 Purple = Smallpox |
| Memory tricks panel | Centripetal vs centrifugal, pleomorphic vs monomorphic, incubation order |
| 18 MCQs | Every high-yield question with the correct disease answer |
| Rapid recall panel | One mini-table per disease — read in 2 minutes |
| Examiner tips | 4 impressive lines covering all 4 diseases together |